Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Teladoc

Teladoc Health Reports Smaller-Than-Expected Q2 Loss, Revenue Tops Estimates

Teladoc Health Inc (NYSE:TDOC) reported second-quarter financial results Tuesday after the bell. Here’s a look at the key highlights from the report.

Benzinga

Teladoc Stock Is a ‘Coiled Spring’ That Could Surge Higher. Should You Buy TDOC Here?

Teladoc stock gains as Citron Research posts a bullish report in its favor. Wall Street remains positive on TDOC shares for the second half of 2025 as well.

Barchart

Citron Research Just Identified This 1 Stock to Buy as a ‘Hidden’ AI Winner

Former short seller Citron Research is growing bullish on Teladoc's growth potential.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Amazon Expands Health Care Offerings Via Teladoc Partnership

Teladoc Health, Amazon announce a new health care partnership to discover and enroll in benefits programs. TDOC stock surges.

Investors Business Daily

2 Telehealth Stocks That Could Gain from Trump’s New FDA Pick

Discover two telehealth stocks, Hims & Hers (HIMS) and Teladoc (TDOC), poised to benefit from Trump's FDA nominee, Dr. Marty Makary, a telemedicine advocate.

MarketBeat

Unveiling 8 Analyst Insights On Teladoc Health

Teladoc Health (NYSE:TDOC) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

Benzinga

2 Former Pandemic Darlings Eyeing a Big 2025 Turnaround

The pandemic triggered a boom in stocks that accommodated physical isolation, convenient access from home and fitness. Many of these stocks hit unbelie

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

3 Healthcare Stocks Innovating with AI

As healthcare rapidly advances, AI-driven technologies present compelling investment opportunities. Hence, investors might find promising potential in fundamentally solid healthcare stocks like Intuitive Surgical (ISRG), Illumina (ILMN), and Teladoc Health (TDOC). Keep reading.

StockNews.com

2 Beaten-Down Growth Stocks With At Least 35% Upside Potential in 2024

While both stocks have fallen significantly from their 52-week highs, there is more upside to come over the longer term.

Barchart

TDOC Stock Forecast 2025: Can Teladoc Recover from Its Record Lows?

Teladoc Health stock fell to record lows on Wednesday. Can the telehealth stock recover from its slump?

Barchart

Is This Cathie Wood Stock an Undervalued AI Play?

Teladoc is a beaten-down telehealth stock that trades at a steep discount to consensus analyst estimates in Q1 of 2024.

Barchart

TDOC Stock: How Low Can This Cathie Wood Favorite Go?

Teladoc Health stock is in the red this year, and is trading near its record lows. How much lower will this Cathie Wood stock go from these levels?

Barchart

2 Cathie Wood Picks to Buy on Weakness in Growth Stocks

While many of the growth stocks in Cathie Wood's portfolio have sold off amid the Fed's rate hikes and tough macro environment, Teladoc Health and SoFi look like two stocks worth buying now.

Barchart

1 Undervalued Stock to Buy Near 52-Week Lows

Pandemic-era favorite Teladoc Health is trading near its 52-week lows. However, a strong growth outlook and attractive valuations make the stock a good buy at these prices.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

3 Stocks to Buy From Wednesday’s Bullish Price Surprises

While the S&P 500 and Dow were relatively flat in Wednesday’s trading, there were some very bullish price surprises from some very popular stocks.

The Guardian - UK

Revealed: NHS England chair fixed meeting for client of bank he advised

David Prior helped arrange a meeting between NHSX and the private care company Teladoc, said to be keen to expand in the UK

Investors Business Daily

Cathie Wood Has Bet Big On These 10 Stocks; Here's How They Performed In 2022

Cathie Wood makes big bets on potential huge winners. But Ark Invest's top 10 holdings, including Tesla and Roku, tumbled in 2022.

Benzinga

This Is What Whales Are Betting On Teladoc Health

Someone with a lot of money to spend has taken a bullish stance on Teladoc Health (NYSE:TDOC). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Why Pandemic Darlings Teladoc, Align Diverged On Their Third-Quarter Reports

Teladoc Health is "hitting its stride," one analyst said Thursday as TDOC stock surged on its third-quarter beat.

Benzinga

Cathie Wood's Funds Deliver Mixed Q3 Results: Ark Founder's Shares Take On Zoom, Roku, Teladoc And Blockchain

Cathie Wood-led ARK Investment Management’s flagship fund ARK Innovation ETF’s (NYSE: ARKK) performance during the third quarter was mixed relative to broad-based indexes, as it outperformed the MSCI World Index but under

Benzinga

Benzinga Before The Bell: Tesla Model Y Delivery Wait Time Shortened In China, Mark Zuckerberg's Sister Emphasizes On Evolution Of Web3, Amazon Succumbs To TikTok Fever And Other Top Financial Stories Thursday, August 18

CNBC

Benzinga

Why Do Teladoc Health Investors Stand Divided? Bank Of America Analyst Weighs In

On July 10, Bank of America Corp (NYSE: BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC).

StockNews.com

After Plummeting from Covid-Induced Highs, is Now a Good Time to Scoop Up Telehealth Stocks?

Telehealth stocks have declined from the Covid-induced highs and are expected to plunge further due to the nation’s return to normalcy. Moreover, the current macroeconomic headwinds are expected to put added pressure on telehealth companies Teladoc Health (TDOC), American Well (AMWL), Hims & Hers Health (HIMS), iRhythm Technologies (IRTC), and…

Benzinga

Is Dario (DRIO) Health Eating Teladoc's (TDOC) Lunch? Q1 Earnings on Tap Thursday After Meeting with Sanofi (SNY)

Teladoc (NYSE: TDOC) stock recently cratered to a new 52 week low following it’s Q1 report. Some of it’s shortfall was attributed by management to longer sales cycles in the insurer and employer space in addition to competitive concerns.

Benzinga

Cathie Wood Calls Teladoc A 'Category Killer' In Compelling Defense Of Recent Buys

Ark Invest's Cathie Wood has been facing harsh criticism about her investing style, partially because she is an easy target as she elects to disclose portfolio moves on a daily basis, but also because sh

1 2

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations